Daily BriefsThematic (Sector/Industry)

Daily Brief Thematic (Sector/Industry): GEM Weekly (15 Jul 2022): Chinese GDP and more

In today’s briefing:

  • GEM Weekly (15 Jul 2022): Chinese GDP, South Korean Rates; Alibaba, Tencent, NetEase, SK Hynix
  • Japan Stock Commentary | Uniqlo, Yaskawa and Money Forward
  • China Healthcare Weekly (July.15)-7th VBP, Policy Correction Signs, Orthopedic Spine Consumables VBP

GEM Weekly (15 Jul 2022): Chinese GDP, South Korean Rates; Alibaba, Tencent, NetEase, SK Hynix

By Wium Malan, CFA

  • The Global Emerging Markets weekly provides a summary of the key news and related developments impacting the largest countries and constituents of the Global Emerging Markets equity indices.
  • Macro data points: Chinese inflation, GDP, industrial production, and retail sales; South Korean and Philippine interest rates
  • Companies mentioned:Alibaba Group (9988 HK), Tencent (700 HK), NetEase (9999 HK), SK Hynix (000660 KS)

Japan Stock Commentary | Uniqlo, Yaskawa and Money Forward

By Mark Chadwick

  • We share weekly commentaries on stocks in our coverage that had a good or bad week 
  • Fast Retailing was the standout performer, trading up 11% this week
  • Wooden spoons for Money Forward and Yaskawa, both lower after reporting earnings

China Healthcare Weekly (July.15)-7th VBP, Policy Correction Signs, Orthopedic Spine Consumables VBP

By Xinyao (Criss) Wang

  • The 7th National VBP released results. 60 kinds of drugs won the bidding successfully, with price reduction of 48% on average. We analyzed its impact on companies. 
  • The newly issued document about the payment management measures for new technology out of CHS-DRG payment scope is a solid encouragement to innovation and an important policy reform signal.
  • The national centralized procurement of orthopedic spine consumables has officially started, which is beneficial to those leading companies with complete product line.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars